Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Otsuka adds new antidiabetic candidates to R&D pipeline

Aug. 18, 1998

TR1, new member of the TNFR superfamily and target for treating metabolic bone diseases

Aug. 18, 1998

L-Glutamine therapy beneficial for sickle cell anemia

Aug. 18, 1998

EC approval granted for Lilly's SERM, Evista

Aug. 17, 1998

Otsuka describes antihyperglycemic effects of coumarin derivatives

Aug. 17, 1998

Y-700, a new kind of xanthine oxidase inhibitor in development at Yoshitomi

Aug. 14, 1998

NPY Y5 receptor antagonist suppresses feeding and reduces body weight in rodents

Aug. 13, 1998

Kissei describes AGE inhibitors for treating diabetic complications

Aug. 13, 1998

Low-dose tamoxifen reduces the risk of bone fracture in elderly women

Aug. 13, 1998

BRMAC recommends approval of Stemgen for stem cell transplant patients

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...